Healio

PreserFlo microshunt leads to minimal transient anterior segment changes

Please provide your email address to receive an email when new articles are posted on . Minimally invasive glaucoma surgery with the PreserFlo microshunt leads to good IOP control. Matteo Carlà, MD, ...
Healio

Preserflo microshunt shows good outcomes out to 2 years in primary open-angle glaucoma

Please provide your email address to receive an email when new articles are posted on . Two-year results of a multicenter European study showed that the Preserflo microshunt, an ab externo filtration ...
Business Wire

Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
Medscape

The PreserFlo Ab-Externo MicroShunt: A Conversation With Dr Ike Ahmed

Iqbal "Ike" K. Ahmed, MD, is a world-renowned ophthalmologist whose clinical work and research focus on glaucoma, complex cataracts, and intraocular lens complications. In 2020, The Ophthalmologist ...
Business Wire

Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...